Фармакология
208 статей · 16 журналов
Журналы подкатегории (16)
- Pharmacological Research · Elsevier (20)
- Biochemical Pharmacology · Elsevier (18)
- British Journal of Clinical Pharmacology · Wiley (15)
- British Journal of Pharmacology · Wiley (15)
- Clinical Pharmacology and Therapeutics · Wiley (15)
- Contemporary Clinical Trials Communications · Elsevier (15)
- Drug Discovery Today · Elsevier (15)
- Pharmacological Research - Natural Products · Elsevier (15)
- Pharmacological Research - Reports · Elsevier (15)
- Phytotherapy Research · Wiley (15)
- Toxicology and Applied Pharmacology · Elsevier (15)
- Vascular Pharmacology · Elsevier (15)
- Pharmaceutical Science Advances · Elsevier (12)
- Intelligent Translational Medicine · Elsevier (6)
- Incretin Research and Therapeutics · Elsevier (1)
- JAPhA Pharmacotherapy · Elsevier (1)
- From drug repurposing to antiviral activity expansion: building antiviral maps from multiple viral trees
- Patient-based evidence in mechanism-based drug repurposing: Challenges and recommendations
- From chemical space to synthetic reality: A framework for makeable-by-design generative AI in drug discovery
- The future of peptide ADMET prediction: Leveraging AI to unlock new possibilities
- Plasmonic biosensor platforms for next-generation personalized medical diagnostics
- Harnessing exosomes for breast cancer: bridging conceptual promise to tangible translational application
- Drug discovery strategies targeting B7-H3 (CD276) in lung and gastric cancers: From biological validation to next-generation small molecules, biologics and cell-based immunotherapies
- Estimating and predicting clinical trial outcomes in China
- Crosstalk between the cell cycle and ferroptosis in tumor cells
- Mutant isocitrate dehydrogenase in cancer: Structural biology, small-molecule inhibitors, and future drug discovery strategies
- Regulatory sandboxes for drug development: from uncertainty to structured evidence generation
- Does Australia’s Reformed R&D Tax Incentive Scheme Spur or Stifle Innovation?
-
Phillyrin Attenuates Glucocorticoid‐Induced Osteoporosis by Suppressing Ferroptosis via the Nrf2/Keap1 Axis
ABSTRACT Extended glucocorticoids treatment is a primary cause of secondary osteoporosis, termed glucocorticoids‐induced osteoporosis (GIOP), characterized by rapid bone loss and an increased fracture risk. Phillyrin (PHI), a natural...
-
Prevalence and determinants of antiseizure medication dispensing among pregnant persons in the United States: A retrospective claims‐based cohort study, 2004–2021
Aim To describe trends and identify factors associated with antiseizure medications (ASMs) dispensing among pregnant persons in the United States. Methods We conducted a retrospective claims‐based cohort study within AMerican PREGNANcy...
-
Macrophage Polarization as a Therapeutic Nexus in Atherosclerosis: Epigenetic‐Metabolic‐Signaling Networks, Herbal Interventions, and Toward Clinical Translation
ABSTRACT Atherosclerosis (AS) remains a leading cause of cardiovascular mortality. Residual inflammatory risk persists despite optimal lipid‐lowering therapy, largely because macrophage phenotypes extend beyond the simple M1/M2...
-
Operationalizing
<scp>ICH E17</scp>
in Multiregional Clinical Trials: A Practical Roadmap for
<scp>AI</scp>
‐Enabled and Quantitative Methods as Enabling Tools
ICH E17 harmonized the design and interpretation of multiregional clinical trials (MRCTs), yet almost a decade after adoption, its operationalization remains inconsistent across several areas: regional definition, assessment of regional...
-
Implementation of
<i>UGT1A1</i>
genotype‐guided dosing of irinotecan in Europe
Aims Uridine diphosphate glucuronosyltransferase 1A1 ( UGT1A1 ) genotype‐guided dosing of irinotecan presents an individualized dosing strategy that improves patient safety while maintaining therapeutic efficacy. Nonetheless, little is...
-
Characterization of endocytosis and intracellular signalling of the gastrin‐releasing peptide receptor in pruritus
Background and Purpose Chronic pruritus (itch) is a widespread issue affecting one in four adults, with unmet needs for effective treatment. G protein‐coupled receptors (GPCRs) are central to itch signalling and represent a major...
-
Glucocorticoid receptor dimerisation controls inflammation and tumour progression in colorectal cancer via a highly specific immune gene network
Background and Purpose The progression of ulcerative colitis (UC) to colorectal cancer (CRC) represents a major clinical challenge. Glucocorticoids (GCs) are widely used for the treatment of UC and also are included in therapeutic...
-
Structural characterisation of the effect of 5‐chloroindole on orthosteric activation of murine 5‐HT
<sub>3A</sub>
receptors
Background and Purpose 5‐HT 3 receptors play a central role in gut–brain signalling, and their hyperactivity is associated with pathologies ranging from chemotherapy‐induced nausea and vomiting to irritable bowel syndrome. While the...
- Issue Information
-
Strengthening medicine availability through enhanced international collaboration: Outcomes from a pilot on global regulatory assessment of manufacturing changes
Medicine shortages continue to represent a critical global health challenge. While causes are multifactorial, issues can be mitigated by measures that increase manufacturing capacity. However, these require regulatory approval, often...
- Spotlight Commentary: Drug‐induced liver injury—Novel biomarkers and epigenetic insights
-
Initiation of lenacapavir with dose escalation in a patient receiving rifabutin: A case report with therapeutic drug monitoring
Lenacapavir is a first‐in‐class HIV‐1 capsid inhibitor with long‐acting pharmacokinetics that enable 6‐monthly subcutaneous dosing after initiation with oral lead‐in. Lenacapavir is a CYP3A4, UGT1A1 and P‐gp substrate; inducers of these...
-
The Evidence Journey in Patient‐Centered Medicine Development: Reflections on Recent Publications in
<i>Clinical Pharmacology & Therapeutics</i>
This Commentary highlights the evidence journey in patient‐centered medicine development: inter‐disciplinary innovations in quantitative methods for Probability of Success enabling rigorous decision‐making; decentralized clinical trials...
-
Population pharmacokinetics and exposure–response analysis of acalabrutinib in patients with untreated mantle cell lymphoma in the ECHO trial
Aims The phase 3 ECHO trial demonstrated superior progression‐free survival (PFS) with acalabrutinib plus bendamustine‐rituximab (BR) versus placebo plus BR in treatment‐naive (TN) mantle cell lymphoma (MCL). This analysis characterizes...
- Interpreting meal‐independent dosing in a fixed‐sequence pharmacokinetic study of elecoglipron
-
Mass balance and metabolite profiles in humans of ACT001, a novel sesquiterpene lactone derivative, using
<sup>14</sup>
C‐radiolabelled techniques
Aims ACT001, a novel sesquiterpene lactone derivative, is effective against treating glioblastoma multiforme and other diseases. This study aims to investigate its metabolic and excretion characteristics. Methods A single oral dose of...
-
Plantamajoside Alleviates Osteoporosis by Suppressing Nrf2 Ubiquitination to Mitigate Oxidative Stress and Mitochondrial Damage
ABSTRACT As a prevalent skeletal disorder, osteoporosis is characterized by reduced bone mass, disrupted bone microarchitecture, and increased bone fragility. Excessive oxidative stress and mitochondrial dysfunction are key contributors...
-
Model‐informed characterisation of the target therapeutic window for dexamethasone by quantitatively balancing foetal lung maturation and neurotoxicity in pregnant rats
Background and Purpose Dexamethasone, a first‐line treatment for neonatal respiratory distress syndrome (NRDS), promotes foetal lung maturation whilst simultaneously inducing neurotoxicity in offspring. We aimed to define the...